<DOC>
	<DOC>NCT02121054</DOC>
	<brief_summary>The purpose of this study is to evaluate the prognosis of patients with resistance to antiplatelet agent and develop tailored treatment model for patients with coronary artery disease.</brief_summary>
	<brief_title>Research of Resistance to Antiplatelet Agents and Development of Tailored Treatment Model for Patients With Coronary Artery Disease</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Platelet Aggregation Inhibitors</mesh_term>
	<criteria>Age ã€‰20 Patients with coronary artery disease Patients with peripheral artery disease Renal dysfunction Hepatic dysfunction Major surgery planned within 1 year Malignant tumor History of gastrointestinal bleeding low or high platelet count</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Antiplatelet Agents</keyword>
	<keyword>Drug Resistance</keyword>
</DOC>